GET Pharmaceutical

GET Pharmaceuticals Pty is a forward-thinking South African biotechnology company specializing in the production of premium cannabinoid-based Active Pharmaceutical Ingredients (APIs) for therapeutic applications. By leveraging cutting-edge extraction and refinement technologies, we are poised to meet the growing global demand for cannabinoid therapies, while ensuring the highest standards of safety and efficacy. “Our mission is to harness the latest advancements in cannabis oil extraction technology to produce, compound, and package high-quality medicinal products that meet the highest pharmaceutical standards. Born from a deeply personal journey and a fervent desire to find natural cures for cancer and other medical conditions, we are committed to making a meaningful difference in the lives of those who need it most. By upholding the highest standards of quality, safety, and compliance, we ensure that every product we create is both effective and reliable. Our dedication to integrity, transparency, and sustainability drives us to set a benchmark in the industry, delivering unparalleled products that support health and well-being.” At GET Pharmaceuticals, we are committed to manufacturing cGMP-compliant cannabinoid APIs, including Δ9-Tetrahydrocannabinol (D9-THC) and Cannabidiol (CBD). Our state-of-the-art production facility in Johannesburg adheres to the most rigorous pharmaceutical manufacturing standards, ensuring consistency, purity, and safety in every batch. The global medical cannabis market is experiencing rapid growth, driven by increased legalization for medical use across multiple regions. In South Africa, the favorable regulatory environment, spearheaded by the South African Health Products Regulatory Authority (SAHPRA), allows for the production and distribution of cannabinoid pharmaceutical ingredients. This regulatory progress, combined with global market trends, positions GET Pharmaceuticals to seize significant opportunities locally and abroad.